$0.37
arrow_drop_down20.40%There's no data available for performance history chart
Key Stats | |
---|---|
Open | $0.55 |
Prev. Close | $0.46 |
EPS | - |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $13.86M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 0.42 | 0.46 |
52 Week Range | 0.00 | 1.89 |
Ratios | |
---|---|
P/B Ratio | 0.00 |
Revenue | - |
Operating M. % | -1071.32% |
Earnings | $0.00 |
Earnings Growth % | -20.29% |
EBITDA Margin % | - |
ROE % | -174.12% |
EPS | - |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Predicted: 21 seconds ago
Analyzed by 27 Wall Street experts, Veracyte 's 12-month projections average at $32.18, spanning from a high of $62.00 to a low of $21.00. This signifies an 5.24% shift from the current price of $30.58.
Buy
Buy | 8 | 72.73% | |
---|---|---|---|
Hold | 2 | 18.18% | |
Sell | 1 | 9.09% |
Last updated: 21 seconds ago
•Total: 11Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.